More tools:Markets·Screener·Research·Chat

Quest Diagnostics Inc. (DGX) Financial Statements

Quest Diagnostics Inc.
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG001S9GX43
XNYS · usd
237.50▲ 0.00 (0.00%)
As of 2026-08-12
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$11.6B
Net Income (TTM)$1.1B
EBITDA
Diluted EPS (TTM)
EBITDA Margin19.1%
Net Debt
Trading Information
Previous Close237.50
Day's Range235.51 – 239.92
52-Week Range171.01 – 240.13
Volume846.7K
Avg Volume1.0M
Share Statistics
Shares Outstanding110.7M
Employees57.0K
ExchangeXNYS
Listed1996-12-17
Loading Income Statement…
Key questions about Quest Diagnostics Inc. (DGX)
What is Quest Diagnostics Inc.'s Market Cap?
Quest Diagnostics Inc.'s Market Cap is $26.3B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Enterprise Value?
Quest Diagnostics Inc.'s Enterprise Value is $43.5B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Trailing P/E?
Quest Diagnostics Inc.'s Trailing P/E is 24.8×, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Price / Sales?
Quest Diagnostics Inc.'s Price / Sales is 2.3×, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s EV / Revenue?
Quest Diagnostics Inc.'s EV / Revenue is 3.8×, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s EV / EBITDA?
Quest Diagnostics Inc.'s EV / EBITDA is 19.7×, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Revenue (TTM)?
Quest Diagnostics Inc.'s Revenue (TTM) is $11.6B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Net Income (TTM)?
Quest Diagnostics Inc.'s Net Income (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s EBITDA?
Quest Diagnostics Inc.'s EBITDA is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Diluted EPS (TTM)?
Quest Diagnostics Inc.'s Diluted EPS (TTM) is 9.59, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net revenues
YoY growth+10.2%+9.2%+7.1%+13.2%
Operating costs and expenses and other operating income:
Cost of services
Selling, general and administrative
Amortization of intangible assets
Other operating expense (income), net
Total operating costs and expenses, net
% of revenue84.9%86.2%86.2%86.3%
Operating income
% of revenue15.1%13.8%13.8%13.7%
Other income (expense):
Interest expense, net
Other income, net
Total non-operating expense, net
Income before income taxes and equity in earnings of equity method investees
Income tax expense
Equity in earnings of equity method investees, net of taxes
Net income
% of revenue11.0%9.1%9.1%9.2%
Basic (in dollars per share)—
Diluted (in dollars per share)—